UNSPSC 85492906: Revision of autologous tissue substitute in great vessel, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of autologous tissue substitute in great vessel, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02WY47Z

UNSPSC 85492906 Revision of autologous tissue substitute in great vessel, percutaneous endoscopic approach (Commodity) shows little relevant recent activity. The code's nominal scope describes a surgical procedure code—revision of tissue substitutes in major blood vessels using endoscopic techniques—but the state and local opportunities posted under this code are unrelated to surgical tissue work. Recent solicitations tagged to this code include independent medical evaluation services for pension disability determinations, health plan surgical carve-out benefit administration, occupational medical surveillance, specialty medical services for youth in custody, pharmacy benefit management, and temporary health professional staffing. None of these solicitations involve tissue substitutes, great-vessel revision, or endoscopic procedures. The mismatch suggests a classification or tagging error in the data rather than actual demand for the tissue-revision procedure itself under this code.

State and local governments are not presently soliciting for autologous tissue substitute revision services under this code. The recent opportunities represent procurement activity by municipal retirement offices (City of Phoenix), city employee benefits programs (City of Long Beach), state transportation agencies (Washington State Department of Transportation), county detention health systems (Harris County), county human resources and benefits consortiums (Collier County), and county health systems (Santa Clara County) across Arizona, California, Florida, and Washington. These diverse jurisdictions and service lines do not align with the code's technical scope, and no forward-looking procurement in tissue-substitute revision has been identified in recent postings.